Participant flow24

How many started, completed or left each group, period by period.

1 to 20 of 24

Period	Milestone	Group	Participants
Overall Study	STARTED	Placebo	27
Overall Study	STARTED	Elagolix 25 mg BID	18
Overall Study	STARTED	Elagolix 50 mg QD	18
Overall Study	STARTED	Elagolix 75 mg BID	18
Overall Study	STARTED	Elagolix 150 mg QD	19
Overall Study	STARTED	Elagolix 300 mg QD	18
Overall Study	Randomized and Treated	Placebo	26
Overall Study	Randomized and Treated	Elagolix 25 mg BID	18
Overall Study	Randomized and Treated	Elagolix 50 mg QD	17
Overall Study	Randomized and Treated	Elagolix 75 mg BID	17
Overall Study	Randomized and Treated	Elagolix 150 mg QD	18
Overall Study	Randomized and Treated	Elagolix 300 mg QD	18
Overall Study	COMPLETED	Placebo	9
Overall Study	COMPLETED	Elagolix 25 mg BID	4
Overall Study	COMPLETED	Elagolix 50 mg QD	5
Overall Study	COMPLETED	Elagolix 75 mg BID	6
Overall Study	COMPLETED	Elagolix 150 mg QD	3
Overall Study	COMPLETED	Elagolix 300 mg QD	7
Overall Study	NOT COMPLETED	Placebo	18
Overall Study	NOT COMPLETED	Elagolix 25 mg BID	14

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03951077/flow